Press Releases Dancann Pharma A/S

Equities

DANCAN

DK0061410487

End-of-day quote NORDIC GROWTH MARKET Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
0.081 ^DKK	+8.00%		+10.05%	+170.00%

03-29	Dancann Pharma Plans Up to DKK19 Million Rights Issue	MT
02-28	DanCann Pharma Notes Cannabis Legalization in Germany as Shares Surge	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING	04-17	AQ
NOTICE OF EXTRAORDINARY GENERAL MEETING IN DANCANN PHARMA A/S	04-02	AQ
DanCann Pharma A/S intends to initiate and complete a partly secured rights issue of up to DKK 18.5 million to restructure, strengthen and secure a debt-free capital structure	03-29	AQ
DanCann Pharma A/S: Germany makes historic move towards cannabis reclassification and legalization	02-28	AQ
DanCann Pharma A/S Reports Fourth Quarter and Full Year 2023 Results	02-28	AQ
DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	01-10	AQ
DanCann Pharma A/S delivers annual shareholder letter and investor update	12-20	AQ
DanCann Pharma A/S: Flagging announcement	11-30	AQ
DanCann Pharma A/S publishes Q3-2023 report	11-30	AQ
DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1	11-28	AQ
DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	11-22	AQ
DanCann Pharma A/S: Future strategic direction	26/10/23	AQ
DanCann Pharma A/S Completes Issuance (5) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	04/10/23	AQ
DanCann Pharma A/S aims to accelerate business and revenue growth: Comprehensive strategy update to follow in October	02/10/23	AQ
DanCann Pharma A/S Completes Issuance (3) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	31/08/23	AQ
DanCann Pharma A/S publishes Q2-2023 report	31/08/23	AQ
DanCann Pharma A/S to refocus its strategy - will reinvigorate its pipeline and product portfolio, and start looking for future owner or partnership for BP1	31/08/23	AQ
DanCann Pharma A/S Completes Issuance of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2	27/07/23	AQ
DanCann Pharma A/S Successfully Receives First Tranche from the 10-Year Financing Loan-Agreement with 12-months Conversion Option and Warrants with Nordic Growth Opportunities 2	17/07/23	AQ
DanCann Pharma A/S: MINUTES OF EXTRAORDINARY GENERAL MEETING	20/06/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Dancann Pharma A/S

Equities

DANCAN

DK0061410487

Press Releases

Filters